XWA-27876-10814
3 vaccinations
5 coded responses
41 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 373 / TN
- Registered
- 2021-01-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-24
Registered in v-safe
-
2021-01-24
Dose 1 — Pfizer-BioNTech
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-07
- 2021-02-14
-
2021-02-15
Dose 2 — Pfizer-BioNTech
- 2021-02-15
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen axillary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen axillary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen axillary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-05-17
- 2021-08-16
-
2021-12-04
Dose 3 — Pfizer-BioNTech
- 2021-12-04
- 2021-12-05
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-26
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-03-05
- 2022-06-05
-
2022-12-04
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous, COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Miscarriage: 6/8/22 Covid-19: 8/24/22MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-24 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen axillary lymph nodes
Systemic reaction (other): Swollen axillary lymph nodes
Systemic reaction (other): Swollen axillary lymph nodes
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen axillary lymph nodes
Release 12 — 12 months, dose 3
Symptoms: Miscarriage: 6/8/22 Covid-19: 8/24/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release